Brainomix
AI medical imaging, Oxford
AI imaging software for stroke and lung fibrosis diagnosis. It raised £4.8m in its Series C in February 2026. It has 0 roles open, 0 of them in the UK.
On the Home Office register of licensed visa sponsors.
Open roles over time
Hiring momentum
Roles per weekNo data yet.
In the news
All 51 stories- OtherFirstWord Pharma, 5 days agoBrainomix's AI software flags potential responders to Remedy's stroke drug
- OtherPR Newswire, 5 days agoBrainomix AI Imaging Analysis of Phase 3 CHARM Trial Identifies Promising Treatment Signals in Severe Stroke Patients
- OtherIn Vivo, 6 days agoBrainomix’s AI-Powered Precision Medicine Stroke Offering Targets Non-Specialist Centers
- OtherYahoo Finance, 13 days agoBrainomix Multicenter Study Demonstrates Potential of Quantitative CT for Earlier Detection of Progressive Pulmonary Fibrosis (PPF)
- OtherAuntMinnie, 19 days agoBrainomix adds patient input to e-Lung lung CT study
- Partnerships & dealsPR Newswire, 19 days agoBrainomix and Pulmonary Fibrosis Foundation Partner to Bring Patient Perspectives to AI-Powered Pulmonary Fibrosis Care